Discover 162 paid clinical trials in South Bend, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Sponsor:
University of Rochester NCORP Research Base
Location:
Code:
NCT03996265
Conditions
Be Diagnosed With Cancer and Have Completed Systemic Therapy
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Bupropion Hydrochloride Controlled-release
Placebo Administration
Quality-of-Life Assessment
Questionnaire Administration
Sponsor:
NRG Oncology
Location:
Code:
NCT04804644
Conditions
Metastatic Lung Small Cell Carcinoma
Metastatic Malignant Neoplasm in the Brain
Recurrent Lung Small Cell Carcinoma
Stage IV Lung Cancer AJCC v8
Stage IVA Lung Cancer AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Memantine Hydrochloride
Neurocognitive Assessment
Stereotactic Radiosurgery
Whole-Brain Radiotherapy
Sponsor:
Boehringer Ingelheim
Location:
Code:
NCT06632444
Conditions
Metabolic Dysfunction Associated Steatohepatitis (MASH)
Liver Fibrosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Survodutide
Placebo
Sponsor:
University of British Columbia
Location:
Code:
NCT04634240
Conditions
Aortic Stenosis
Coronary Artery Disease
Coronary Stenosis
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Percutaneous Coronary Intervention (PCI)
Sponsor:
NRG Oncology
Location:
Code:
NCT05095376
Conditions
Glioblastoma
Gliosarcoma
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Not accepted
Interventions
Lomustine
Photon Beam Radiation Therapy
Quality-of-Life Assessment
Questionnaire Administration
Temozolomide
Sponsor:
AstraZeneca
Location:
Code:
NCT06268873
Conditions
Chronic Kidney Disease and Hypertension
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Baxdrostat/dapagliflozin
Dapagliflozin in combination with placebo
Sponsor:
Kartos Therapeutics, Inc.
Location:
Code:
NCT04502394
Conditions
Diffuse Large B Cell Lymphoma
Chronic Lymphocytic Leukemia
Non Hodgkin Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
KRT-232
acalabrutinib